Scarica l'app Stockscreener
15.72
2.95%
0.45
Precedente Chiudi:
$15.27
Aprire:
$15.41
Volume 24 ore:
123.29K
Relative Volume:
0.49
Capitalizzazione di mercato:
$975.10M
Reddito:
-
Utile/perdita netta:
$-48.26M
Rapporto P/E:
-19.90
EPS:
-0.7899
Flusso di cassa netto:
$-45.04M
1 W Prestazione:
+7.89%
1M Prestazione:
-0.25%
6M Prestazione:
+24.86%
1 anno Prestazione:
+81.52%
Intervallo 1D:
$15.17
$15.90
Intervallo di 1 settimana:
$14.33
$15.90
Portata 52W:
$8.45
$19.51
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
15.72 | 975.10M | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
436.27 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
748.87 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
799.65 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
322.11 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
309.66 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
GHRS Price Today: GH Research PLC Stock Price, Quote & Chart | MEXC - MEXC
Avoiding Lag: Real-Time Signals in (GHRS) Movement - Stock Traders Daily
Risk Off: Is GH Research PLC stock forming a cup and handle2026 Major Catalysts & Expert-Curated Trade Recommendations - baoquankhu1.vn
Risk Recap: Is GH Research PLC stock undervalued right now2026 Technicals & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Support Test: Is GH Research PLC a turnaround story2026 Volume Leaders & Stock Timing and Entry Methods - baoquankhu1.vn
Net current asset value per share of GH Research Plc – DUS:1KA - TradingView
GH Research (NASDAQ: GHRS) COO details multiple share option grants - Stock Titan
GH Research PLC (GHRS) director details share and option holdings - Stock Titan
GH Research (GHRS) executive details direct shares and option grants - Stock Titan
GH Research (NASDAQ: GHRS) director details initial share and option positions - Stock Titan
GH Research (NASDAQ: GHRS) CEO reports sizeable option grants and vesting - Stock Titan
GH Research (GHRS) VP, Finance reports multiple option grants - Stock Titan
GH Research (GHRS) director discloses 14.8M Ordinary Shares in Form 3 - stocktitan.net
GH Research (GHRS) price target increased by 18.94% to 40.04 - MSN
S P Trends: What are the risks of holding GH Research PLC2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
GH Research (NASDAQ:GHRS) Shares Gap DownShould You Sell? - MarketBeat
Discipline and Rules-Based Execution in GHRS Response - Stock Traders Daily
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics - The Chronicle-Journal
Short Squeeze: What is the dividend yield of GH Research PLCTrade Volume Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
GH Research publishes phase 2b results for depression treatment By Investing.com - Investing.com Australia
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy - The Globe and Mail
GH Research PLC (GHRS) stock: Clinical Trial Success Signals Potential Shift in Depression Treatment - parameter.io
GH Research publishes phase 2b results for depression treatment - Investing.com
GH Research PLC Announces Peer-Reviewed Publications of Phase 2b Results for GH001 in Treatment-Resistant Depression - Quiver Quantitative
GH Research (Nasdaq: GHRS) reports Phase 2b TRD results for GH001 - Stock Titan
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA ... - Caledonian Record
GH Research Announces Publication of Phase 2b Results for - GlobeNewswire
Depression drug worked despite multiple prior treatment failures - Stock Titan
What Does GH Research PLC (GHRS)’s Clinical Progress Updates Say? - Insider Monkey
5 Best Psychedelic Stocks to Buy in 2026 - Insider Monkey
Aug Outlook: What is the dividend yield of GH Research PLCWeekly Stock Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
GHRS PE Ratio & Valuation, Is GHRS Overvalued - Intellectia AI
GH Research PLC: Fundamental Analysis and Financial Ratings | | IE000GID8VI0 - marketscreener.com
Behavioral Patterns of GHRS and Institutional Flows - Stock Traders Daily
Buyout Rumor: Can GH Research PLC ride the EV wave2026 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn
Growth Value: Can Embrace Change Acquisition Corp Equity Right maintain sales growthMarket Sentiment Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
GH Research PLC (NASDAQ:GHRS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat - TipRanks
GH Research PLC (NASDAQ: GHRS) to join fireside chat at Stifel 2026 Virtual CNS Forum - Stock Titan
HighVista Strategies LLC Grows Stake in GH Research PLC $GHRS - MarketBeat
Analysts Set Expectations for GH Research Q1 Earnings - MarketBeat
Whale Trades: Is GH Research PLC stock undervalued right nowGap Up & Safe Swing Trade Setup Alerts - baoquankhu1.vn
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 - Seeking Alpha
Guggenheim raises GH Research stock price target to $34 on trial data - Investing.com Australia
Guggenheim raises GH Research stock price target to $34 on trial data By Investing.com - Investing.com India
GH Research reports Phase 2b trial results for depression treatment - Investing.com Nigeria
Activity Recap: Does GH Research PLC stock benefit from AI growthQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
(GHRS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Aug Ideas: Can GH Research PLC ride the EV waveJuly 2025 Closing Moves & Weekly Market Pulse Updates - baoquankhu1.vn
HC Wainwright Forecasts Reduced Earnings for GH Research - Defense World
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
3.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):